TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2416566

Group type: EXPERIMENTAL
Intervention: Pirmenol, 200 mg twice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31775313

Group type: EXPERIMENTAL
Intervention: MapReduce-based parallel genetic algorithm (MR-based PGA) for selecting age-related CpG-sites
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Gradient Boosting Regressor (GBR) model built on selected CpG-sites from the train set
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Parallelized execution of the algorithm
Number of subjects: 16
Study: 29633507

Group type: EXPERIMENTAL
Intervention: GV1001 0.4 mg, 2‐week interval
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: GV1001 0.56 mg, 2‐week interval
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: GV1001 0.56 mg, 4‐week interval
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 27062417

Group type: EXPERIMENTAL
Intervention: mCIMT combined with auditory feedback
Number of subjects: 20

Group type: COMPARATOR
Intervention: mCIMT
Number of subjects: 20
Study: 24316088

Group type: EXPERIMENTAL
Intervention: Nicotine (Nicorette Freshmint 2mg, polacrilex chewing gum)
Number of subjects: 16
Study: 23328419

Group type: EXPERIMENTAL
Intervention: Modified stent
Number of subjects: 380

Group type: COMPARATOR
Intervention: Conventional stent
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Both stents
Number of subjects: 380
Study: 21409315

Group type: EXPERIMENTAL
Intervention: Casein (Cas-meal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Whey (Whe-meal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cod (Cod-meal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Gluten (Glu-meal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All protein sources
Number of subjects: 12
Study: 18191383

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Perphenazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quetiapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risperidone vs Quetiapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall treatment groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Symptom reduction and global improvement
Number of subjects: 0
Study: 16417827

Group type: EXPERIMENTAL
Intervention: Colgate Simply White Night (consumer-available)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Crest Night Effects (consumer-available)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Opalescence (dentist-prescribed, home-applied)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 12889397

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression pump at 40 mmHg pressure, 10 second deflation time, 15 second inflation time
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression pump at 30 mmHg pressure
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression pump at 35 second deflation time
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression pump at 5 second inflation time
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression pump at 45 second inflation time
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (elevating both lower limbs)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression pump at 70 mmHg pressure
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression pump at 60 mmHg pressure
Number of subjects: 27
Study: 10228867

Group type: EXPERIMENTAL
Intervention: 5‐FU plus bolus infusion of CDDP (A‐1, B‐1)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 5‐FU plus continuous infusion of low‐dose CDDP (A‐2, B‐2)
Number of subjects: 73
Study: 8910155

Group type: EXPERIMENTAL
Intervention: Dobutamine, 10 micrograms/kg/min
Number of subjects: 30

Group type: COMPARATOR
Intervention: Enoximone, 20 micrograms/kg/min
Number of subjects: 30
Study: 1887821

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated estrogen daily plus variable-resistance weight training
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.625 mg conjugated estrogen daily
Number of subjects: 20
Study: 6089632

Group type: EXPERIMENTAL
Intervention: BCVPP (carmustine, cyclophosphamide, vinblastine, procarbazine, and prednisone)
Number of subjects: 293

Group type: COMPARATOR
Intervention: MOPP (mechlorethamine hydrochloride, vincristine, procarbazine, and prednisone)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: BCVPP
Number of subjects: 293
Study: 31601239

Group type: EXPERIMENTAL
Intervention: HemoSphere with HPI used to guide treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: HemoSphere with HPI software connected but fully covered (control)
Number of subjects: 100
Study: 29659672

Group type: EXPERIMENTAL
Intervention: ADI-PEG 20 18 mg/m2
Number of subjects: 635

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 635
Study: 27502583

Group type: EXPERIMENTAL
Intervention: Internet‐mediated, pedometer‐based walking intervention (Taking Healthy Steps)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 239
Study: 24491874

Group type: EXPERIMENTAL
Intervention: Heated water-based exercise (HEx)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (maintained habitual activities)
Number of subjects: 32
Study: 22632109

Group type: EXPERIMENTAL
Intervention: Robotic Prostatectomy
Number of subjects: 400

Group type: COMPARATOR
Intervention: Open Prostatectomy
Number of subjects: 400
Study: 20970650

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Tacrolimus (Tac)
Number of subjects: 36
Study: 22489072

Group type: EXPERIMENTAL
Intervention: 7-item predictive score including age <1 year, epilepsy, congenital/genetic conditions, history of transplant, enteral tube, hemoglobin <10 g/dL, blood culture drawn in the preceding 72 hours
Number of subjects: 564

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 564
Study: 15567879

Group type: EXPERIMENTAL
Intervention: GnRH antagonist + rFSH
Number of subjects: 82

Group type: COMPARATOR
Intervention: rFSH alone
Number of subjects: 82
Study: 14526713

Group type: EXPERIMENTAL
Intervention: EPs 7630 (20 drops tid for 6 days)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo (20 drops tid for 6 days)
Number of subjects: 143

Group type: COMPARATOR
Intervention: EPs 7630 vs Placebo
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: EPs 7630
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 10586932

Group type: EXPERIMENTAL
Intervention: Etafilcon A lens
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lotrafilcon A lens
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control eyes paired with Etafilcon A lens
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control eyes paired with Lotrafilcon A lens
Number of subjects: 20
Study: 8901789

Group type: EXPERIMENTAL
Intervention: 300 g Brussels sprouts/d for 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: 150 mg eugenol/d in capsule form
Number of subjects: 0
Study: 1876744

Group type: EXPERIMENTAL
Intervention: Mepivacaine 1% 40 ml + phentanyl 100 micrograms
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mepivacaine 1% 40 ml + subcutaneous phentanyl 100 micrograms
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mepivacaine 1% 40 ml (control group)
Number of subjects: 60
Study: 6283645

Group type: EXPERIMENTAL
Intervention: tiapride (900 mg per day for three months)
Number of subjects: 25

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: tiapride
Number of subjects: 25
Study: 29437181

Group type: EXPERIMENTAL
Intervention: Extensive intervention (motivational interviewing within a web-based health risk assessment)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Limited intervention (web-based health risk assessment only)
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Extensive intervention (motivational interviewing)
Number of subjects: 491
Study: 27143213

Group type: EXPERIMENTAL
Intervention: Dabigatran 220 mg once daily (starting with 110 mg half-dose, 1-4 hours after surgery)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg once daily (starting the evening before surgery)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 179

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Dabigatran and Enoxaparin
Number of subjects: 179
Study: 26121789

Group type: EXPERIMENTAL
Intervention: Isotonic electrolyte solution with 1% glucose (IT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hypotonic electrolyte solution with 2.6% glucose (HT)
Number of subjects: 50
Study: 23796291

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 15212

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 15212
Study: 20572419

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 18424323

Group type: EXPERIMENTAL
Intervention: ISA247 0.2 mg/kg
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: ISA247 0.3 mg/kg
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: ISA247 0.4 mg/kg
Number of subjects: 451

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451
Study: 16844623

Group type: EXPERIMENTAL
Intervention: Leukocyte filter (LeukoGuard LG6)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (without leukocyte filter)
Number of subjects: 20
Study: 12925471

Group type: EXPERIMENTAL
Intervention: Etomidate 0.2 mg kg(‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Etomidate 0.3 mg kg(‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Etomidate 0.4 mg kg(‐1)
Number of subjects: 30
Study: 10683103

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) supplementation (5 g of Cr plus 1 g of sucrose 4x per day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (6 g of sucrose placebo 4x per day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) supplementation
Number of subjects: 17

Group type: COMPARATOR
Intervention: Creatine (Cr) supplementation and Placebo
Number of subjects: 17
Study: 8877825

Group type: EXPERIMENTAL
Intervention: Notetaking
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Essay writing
Number of subjects: 118

Group type: COMPARATOR
Intervention: No writing (Control)
Number of subjects: 118
Study: 1799190

Group type: EXPERIMENTAL
Intervention: Ioxitalamate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ioxaglate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Iopamidol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 60
Study: 6630548

Group type: EXPERIMENTAL
Intervention: Faking groups (Right, Left, Diffuse, Nonspecific)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 254
Study: 30357297

Group type: EXPERIMENTAL
Intervention: Myo-inositol (40 mg/kg every 12 hours for up to 10 weeks)
Number of subjects: 638

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Myo-inositol
Number of subjects: 638
Study: 26846898

Group type: EXPERIMENTAL
Intervention: Surgical trainee research collaboratives
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Publications from surgical trainee research collaboratives
Number of subjects: 24
Study: 24910270

Group type: EXPERIMENTAL
Intervention: Undecylenoyl phenylalanine 2%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 40
Study: 23083952

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 71

Group type: COMPARATOR
Intervention: No medication (Control)
Number of subjects: 71
Study: 19828909

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin therapy
Number of subjects: 591
Study: 18441040

Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional rehabilitation (Control)
Number of subjects: 30
Study: 15706548

Group type: EXPERIMENTAL
Intervention: Positioning the affected shoulder in maximum comfortable external rotation for 30 minutes, 5 days a week, for 4 weeks.
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Positioning the affected shoulder in 90 degrees of flexion for 30 minutes, 5 days a week, for 4 weeks.
Number of subjects: 31
Study: 11900495

Group type: EXPERIMENTAL
Intervention: Training program based on behavioral theory and practice with standardized patients
Number of subjects: 251
Study: 10200742

Group type: EXPERIMENTAL
Intervention: Amisulpride 50 mg/day
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Amisulpride 100 mg/day
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study: 8848950

Group type: EXPERIMENTAL
Intervention: Moclobemide (400-600 mg/day)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Clomipramine (100-150 mg/day)
Number of subjects: 191
Study: 2330930

Group type: EXPERIMENTAL
Intervention: Oral rhesus rotavirus vaccine at a dose of 10(4) plaque‐forming units
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 45412

Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Complete revascularization
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Incomplete revascularization
Number of subjects: 100
Study: 30529686

Group type: EXPERIMENTAL
Intervention: Condition with two control responses
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Condition with four control responses
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control responses (inactive control response)
Number of subjects: 20
Study: 28938896

Group type: EXPERIMENTAL
Intervention: Endometrial injury in proliferative phase (group A, n = 38)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Endometrial injury in luteal phase (group B, n = 32)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Non-injury in proliferative phase (group C, n = 36)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Non-injury in luteal phase (group D, n = 36)
Number of subjects: 142
Study: 25652873

Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted H5N1 influenza vaccine (1·9 μg or 3·75 μg hemagglutinin antigen)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Seasonal trivalent influenza vaccine
Number of subjects: 405
Study: 23204169

Group type: EXPERIMENTAL
Intervention: Hepatitis A virus (HAV) vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 21454745

Group type: EXPERIMENTAL
Intervention: Beetroot (BR) juice
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 8
Study: 19101234

Group type: EXPERIMENTAL
Intervention: Weight loss during hospitalization (average 3.6 kg)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Weight loss categorized into 3 tertiles
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Days alive out of the hospital in the first 6 months
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: 180-day death
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Death or rehospitalization at 180 days
Number of subjects: 433
Study: 17786744

Group type: EXPERIMENTAL
Intervention: Assessment criteria available for reference on the medical school website
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Students received the assessment criteria for use in discussion and feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Students graded their own performance, peer assessment, tutor assessment, and actor assessment using standard assessment criteria
Number of subjects: 0
Study: 15572199

Group type: EXPERIMENTAL
Intervention: Tobramycine eye drops alone or in combination with cyclosporine A, diclofenac, or rimexolone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rimexolone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aqueous humor from uninflamed human
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aqueous humor from rabbit
Number of subjects: 0
Study: 11759134

Group type: EXPERIMENTAL
Intervention: Viewing a video demonstrating pediatric mask induction (group 1; n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Information pamphlet only (group 2; n = 40)
Number of subjects: 80
Study: 9921608

Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 7702060

Group type: EXPERIMENTAL
Intervention: Nicotinic acid (1.5 g twice a day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lovastatin (40 mg/d)
Number of subjects: 12
Study: 2198822

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin-G (IVIG)
Number of subjects: 0
Study: 904877

Group type: EXPERIMENTAL
Intervention: Iris-clip lens implants
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intracapsular lens extraction
Number of subjects: 46
Study: 31238203

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA) diagnosis
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Age, male sex, and higher Body Mass Index (BMI)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Daytime sleepiness and insomnia
Number of subjects: 125
Study: 27987094

Group type: EXPERIMENTAL
Intervention: Benzydamine rinses (0.15%)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control chemoradiotherapy (saline mouth rinses)
Number of subjects: 120
Study: 26048185

Group type: EXPERIMENTAL
Intervention: Dapagliflozin/metformin XR FDC tablets (5 mg/500 mg in study 1; 10 mg/1000 mg in study 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapagliflozin/metformin XR FDC tablets (administered with a light-fat meal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapagliflozin/metformin XR FDC tablets
Number of subjects: 0
Study: 23354187

Group type: EXPERIMENTAL
Intervention: Routine heparin R‐AHD
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Half-dose heparin R‐AHD
Number of subjects: 10

Group type: COMPARATOR
Intervention: Routine heparin DNHD (control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Routine heparin-mixed AHD PR
Number of subjects: 10
Study: 21653990

Group type: EXPERIMENTAL
Intervention: Weight loss and low-intensity exercise program (WL+LEX)
Number of subjects: 35
Study: 19342867

Group type: EXPERIMENTAL
Intervention: Candesartan (n = 15)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Valsartan (n = 15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 45
Study: 16188495

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 64
Study: 12821546

Group type: EXPERIMENTAL
Intervention: PTFE-covered JoStent coronary stent graft
Number of subjects: 301

Group type: COMPARATOR
Intervention: SS JoFlex stent (control)
Number of subjects: 301
Study: 10687746

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low dose of propofol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Deep anesthetic level with propofol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Thiamylal (control)
Number of subjects: 15
Study: 8932015

Group type: EXPERIMENTAL
Intervention: Air-fluidised bed therapy at 32 degrees C (Group B)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard intensive care unit bed at 22 degrees C (Group A)
Number of subjects: 14
Study: 1873204

Group type: EXPERIMENTAL
Intervention: Oral therapy (8-methoxypsoralen)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bath treatment (8-methoxypsoralen)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study: 6355795

Group type: EXPERIMENTAL
Intervention: Tinidazole and Cephamandole
Number of subjects: 211

Group type: COMPARATOR
Intervention: Tinidazole and Placebo
Number of subjects: 211

Group type: COMPARATOR
Intervention: Tinidazole alone
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (Tinidazole and Cephamandole)
Number of subjects: 211
Study: 3905469

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional insulin therapy (CIT)
Number of subjects: 12
Study: 30326639

Group type: EXPERIMENTAL
Intervention: Reduced dairy intake (−14.6 ± 3.0 g/day)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Maintained dairy intake (−4.0 ± 2.0 g/day)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Increased dairy intake (+13.8 ± 4.1 g/day)
Number of subjects: 102

Group type: COMPARATOR
Intervention: All groups (reduced, maintained, increased)
Number of subjects: 102
Study: 26764321

Group type: EXPERIMENTAL
Intervention: 20 g LNS (Lipid-Based Nutrient Supplement)
Number of subjects: 1320

Group type: COMPARATOR
Intervention: 60 mg iron + 400 μg folic acid (IFA)
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Multiple micronutrients (MMNs)
Number of subjects: 1320
Study: 25496514

Group type: EXPERIMENTAL
Intervention: LCT/CBT
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Avoid/CBT
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 120
Study: 22555894

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone 1 mg/kg/d (tapered gradually)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intrapolyp injection of triamcinolone acetonide (0.3 mL, 40 mg/mL)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Topical triamcinolone acetonide (55 µg, 2 times daily for 1 month)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No medication (control group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone vs Topical triamcinolone
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intrapolyp injection vs Oral methylprednisolone
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intrapolyp injection vs Topical triamcinolone
Number of subjects: 48